British drugmaker GW Pharmaceuticals is testing a marijuana-based drug it believes may be useful in treating obesity by suppressing the appetite, according to a published report. While marijuana is typically known for its appetite-boosting effects, Dr. Stephen Wright, director of GW Pharma’s research and development department, told The Telegraph recently that two specific…